Bio-Techne
TECH
#1486
Rank
โ‚ฌ11.21 B
Marketcap
70,59ย โ‚ฌ
Share price
2.49%
Change (1 day)
-0.03%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚ฌ0.38 Billion

According to Bio-Techne's latest financial reports the company's total debt is โ‚ฌ0.38 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2024)

Total debt by year

Year Total debt Change
2023-06-30โ‚ฌ0.41 B34.16%
2022-06-30โ‚ฌ0.31 B-11.69%
2021-06-30โ‚ฌ0.35 B-8.33%
2020-06-30โ‚ฌ0.38 B-13.1%
2019-06-30โ‚ฌ0.44 B53.12%
2018-06-30โ‚ฌ0.28 B-3.59%
2017-06-30โ‚ฌ0.30 B250.99%
2016-06-30โ‚ฌ85.6 M24.73%
2015-06-30โ‚ฌ68.63 M623.33%
2014-06-30โ‚ฌ9.48 M
2006-06-30โ‚ฌ10.5 M-13.11%
2005-06-30โ‚ฌ12.08 M-7.12%
2004-06-30โ‚ฌ13.01 M-12.88%
2003-06-30โ‚ฌ14.93 M-17.88%
2002-06-30โ‚ฌ18.19 M-18.38%
2001-06-30โ‚ฌ22.28 M7.82%
2000-06-30โ‚ฌ20.66 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚ฌ34.06 B 8,752.20%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.33 B 247.97%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ19.40 B 4,941.14%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ16.90 B 4,292.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.85 B 381.26%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚ฌ19.22 B 4,894.01%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.38 M-99.12%๐Ÿ‡บ๐Ÿ‡ธ USA